Kunbo Medical-B (02216) issued an announcement. On November 24, 2023, Broncus Medical Inc., a subsidiary of the company, was announced. (Broncus Medical) and Nuotron Intelligent Medical Technology (Hangzhou) Co., Ltd. (Nuotron) entered into a termination agreement. Broncus Medical and Nuochuang agreed to a license agreement with an end date of September 7, 2021, effective November 24, 2023.
On September 7, 2021, Broncus Medical entered into a licensing agreement with Nuotron. Broncus Medical agreed to grant Nuotron an inalienable, non-transferable, non-transferable and non-exclusive license to the intellectual property related to navigation, diagnosis and treatment technology acquired by Nuotron in the field of robot-assisted medical intervention on or before the date of the license agreement in specific countries or regions around the world. The license agreement will come into effect on the date of the license agreement (that is, September 7, 2021) and will continue until the final expiration of the patent license introduced under the license agreement expires, and Nuotron must pay Broncus Medical a license fee of 250,000 US dollars a year for ten years.